Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.

Autor: Hentzen, Stijn¹ (AUTHOR), Meirson, Tomer² (AUTHOR), Koehn, Kelly¹ (AUTHOR), Goodman, Aaron³ (AUTHOR), Chakraborty, Rajshekhar⁴ (AUTHOR), Sborov, Douglas⁵ (AUTHOR), Rubinstein, Samuel⁶ (AUTHOR), Mohyuddin, Ghulam Rehman⁵ (AUTHOR) g.mohyuddin@hci.utah.edu

Publikováno v: European Journal of Haematology. Sep2023, Vol. 111 Issue 3, p491-498. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Attrition and Withdrawal Amongst Patients with Multiple Myeloma Participating in Randomized Clinical Trials: A Systematic Review

Autor: Hentzen, Stijn ^*, Meirson, Tomer ^*, Koehn, Kelly, Goodman, Aaron M, Chakraborty, Rajshekhar, Prasad, Vinay ^*, Sborov, Douglas W., Mohyuddin, Ghulam Rehman

Publikováno v: In Blood 15 November 2022 140 Supplement 1:7950-7951

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era.

Autor: Radford M; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS, USA., Abushukair H; Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan., Hentzen S; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS, USA., Cavalcante L; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Saeed A; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Publikováno v: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2023 Jun 22; Vol. 6 (3), pp. 150-157. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).